AzTrials
AzTrials

Gingival RecessionNCT05783258

Connective Tissue Graft From Tuberosity Area and L-PRF Associated With Coronally Advanced Flap for Root Coverage

A study testing Periodontal surgery with CAF+tSCTG and Periodontal surgery with CAF+L-PRF in people with Gingival Recession, run by G. d'Annunzio University at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present randomized controlled clinical study is to compare the efficacy of subepithelial connective tissue graft harvested from the maxillary retromolar tubeosity area and L-PRF membranes in the treatment of RT1 recessions by coronally advanced flap. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gingival Recession
What is being tested?
Periodontal surgery with CAF+tSCTG and Periodontal surgery with CAF+L-PRF
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
13 Jun 2022to 29 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Presence of a class RT1 recession;
  • age > 18 years;
  • systemic health conditions that do not affect the periodontium;
  • Non smoker;
  • FMPS and FMBS values < 20% before the surgical procedure;
  • absence of implants or subgingival restorations in the sites to be treated;
  • presence of adequate tissue distal to the last maxillary molar.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Michele Paolantonio

    Pescara, 65121

Other trials in Italy

About this study

Official title: Comparative Evaluation of the Coronally Advanced Flap (CAF) Using a Connective Tissue Graft From the Tuberosity (tCTG) or L-PRF Membranes: a Randomized Controlled Clinical Trial.

The aim of the present randomized controlled clinical study is to compare the efficacy of subepithelial connective tissue graft harvested from the maxillary retromolar tubeosity area and L-PRF membranes in the treatment of RT1 recessions by coronally advanced flap.

A total of 30 patients will be recruited and randomly assigned to the test group treated with CAF+tSCTG or the control group treated with (CAF+L-PRF). For each experimental site the parameters of gingival recession (GR), pocket depth (PD), clinical attachment level (CAL), keratinized gingiva width (KT) and gingival thickness (GT) will be analyzed at baseline (T0) and at 12 months after the surgical procedure (T1). In addition, was also evaluated the different morbidity of the two surgical techniques, using the VAS scale values recorded in the first 2 weeks following surgery. It was checked the Patient Related Esthetic Score and Dentine hypersensivite reduction.

Being tested
Periodontal surgery with CAF+tSCTG, Periodontal surgery with CAF+L-PRF
Keywords
Root coverage, Periodontal plastic surgery
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Periodontal surgery with CAF+tSCTGProcedure or surgery

    Coronally advanced flap and subepithelial connective tissue graft harvested from the maxillary tuberosity area.

  • Periodontal surgery with CAF+L-PRFProcedure or surgery

    Coronally advanced flap and L-PRF membranes

Study groups in NCT05783258
Study groupRoleWhat they receive
CAF+tSCTGExperimental15 sites will be treated.The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1 mm, 2 horizontal incisions of approximately 3 mm will be made at the base of the surgical papillae laterally to the recession.Two divergent releasing incisions will be made extending approximately 2-3 mm into the alveolar mucosa.The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of the crest bone.A partial thickness dissection will be performed in the most apical portion of the flap until complete passivation of the flap is obtained.The harvesting of the epithelial-connective graft will be performed at the level of the maxillary tuberosity. The de-epithelialised graft will be sutured at the level of the de-epithelialised anatomical papillae.The flap will be repositioned coronally suturing the anatomical papillae on the surgical ones.
Receives: Procedure: Periodontal surgery with CAF+tSCTG
CAF+L-PRFActive comparator15 sites will be treated.The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1 mm,2 horizontal incisions of approximately 3 mm will be made at the base of the surgical papillae laterally to the recession. Two divergent releasing incisions will be made extending approximately 2-3 mm into the alveolar mucosa. The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of bone.A partial thickness dissection will be performed in the apical portion of the flap to obtain complete passivation.The L-PRF membranes will be realized centrifuged venous blood collected in two 10-ml sterile tubes at 3000 rpm for 10 minutes and squeezing the fibrin clot. L-PRF membranes will be superimposed to crete a double layer of about 2 mm thickness.The flap will be repositioned coronally suturing the anatomical papillae on the surgical ones.
Receives: Procedure: Periodontal surgery with CAF+L-PRF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gingival thickness

    Gingival tissue thickness 2 mm apical to the recession

    Measured: 12 months

Secondary outcomes (5)
  1. Keratinized tissue height

    Distance between gingival margin and Mucogingival Junction

    Measured: 12 months

  2. Gingival recession

    Distance from cementoenamel junction and gingival margin

    Measured: 12 months

  3. Complete root coverage

    Percentage of experimental sites that achieved complete root surface coverage.

    Measured: 12 months

  4. Clinical attachment level

    Distance between cementoenamel junction(CEJ) and depth of the pocket

    Measured: 12 months

  5. Pocket depth

    Distance between gingival margin and bottom of the pocket

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2023
  2. Study start13 Jun 2022
  3. Primary completion29 Oct 2023
  4. Study completion29 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05783258
Sponsor's protocol ID
13032023
Status last verified
Nov 2023
First submitted
13 Mar 2023
Last updated
21 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Periodontal surgery with CAF+tSCTG and Periodontal surgery with CAF+L-PRF in people with Gingival Recession, run by G. d'Annunzio University at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gingival thickness (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in